The FDA plans to roll out its new AI tool, called Elsa, "ahead of schedule and under budget," according to Commissioner Dr. Marty Makary, who offered up the most information to date about the agency's ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help agency staff in drug clinical evaluations and reviews. FDA Artificial ...
The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations. Elsa's deployment comes nearly a month ahead of ...
With artificial intelligence being adopted rapidly, varied domains are increasingly looking for ways to implement the technology in order to improve efficiency and save time. We see a vast use of AI ...
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, ...
Editor's note: The story and headline were updated on 23 June to provide additional context on the design of Elsa. WASHINGTON – The US Food and Drug Administration (FDA) plans to make significant ...
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era. Reading time 2 minutes Generative artificial intelligence has found another home in the ...
On June 2, 2025, the U.S. Food and Drug Administration (FDA) announced the deployment of its own artificial intelligence system, “Elsa.” The large language model-powered system was scheduled for ...
The U.S. Food and Drug Administration (FDA) has launched Elsa, an AI tool designed to modernize and speed up agency-wide operations ranging from scientific reviews to investigations. Marty Makary, the ...
The US Food and Drug Administration’s (FDA) new artificial intelligence (AI) assistant, Elsa, has received mixed reviews from agency staff who spoke to Focus. While some staff say the tool has been ...
The FDA announced it will extend the rollout of its generative artificial intelligence platform, Elsa, agency-wide by June 30, 2025. The agency's internal generative AI tool is intended to assist FDA ...